(Prescription Attached):-

đŠē Prescription Analysis & Clinical Diagnosis:-
ENT Prescription Review | Evidence-Based Clinical Assessment
āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύāĻāĻŋ āĻŦāĻŋāĻļā§āϞā§āώāĻŖ āĻāϰ⧠āĻĻā§āĻāĻž āϝāĻžāĻā§āĻā§, āϰā§āĻā§āϰ āĻĄāĻžāύ āĻāĻžāύ⧠Endoscopic Tympanoplasty āĻāϰāĻž āĻšāϝāĻŧā§āĻāĻŋāϞāĨ¤ āĻŦāϰā§āϤāĻŽāĻžāύ⧠āĻ āĻĒāĻžāϰā§āĻļāύā§āϰ āĻĒāϰ Follow-up examination-āĻ āĻĄāĻžāύ āĻāĻžāύā§āϰ āĻā§āϤāϰā§āϰ āĻ āĻāĻļ āĻāĻŋāĻā§āĻāĻž āĻā§āĻāĻž āĻĒāĻžāĻāϝāĻŧāĻž āĻā§āĻā§āĨ¤
āĻāĻŋāĻāĻŋā§āϏāĻ āĻŽā§āĻ ā§ĒāĻāĻŋ āĻāώā§āϧ āĻĻāĻŋāϝāĻŧā§āĻā§āύāĨ¤ āĻāϰ āĻŽāϧā§āϝ⧠āĻāĻāĻāĻŋ āĻļāĻā§āϤāĻŋāĻļāĻžāϞ⧠āĻ ā§āϝāĻžāύā§āĻāĻŋāĻŦāĻžāϝāĻŧā§āĻāĻŋāĻ (Linezolid), āĻāĻāĻāĻŋ āĻ ā§āϝāĻžāύā§āĻāĻŋāĻšāĻŋāϏā§āĻāĻžāĻŽāĻŋāύ, āĻāĻāĻāĻŋ Antibiotic + Steroid ear drop āĻāĻŦāĻ āĻāĻāĻāĻŋ Nasal decongestant āϰāϝāĻŧā§āĻā§āĨ¤
āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ: āĻāĻŋāĻāĻŋā§āϏāĻ āĻāϞāĻžāĻĻāĻž āĻāϰ⧠āĻā§āύ⧠āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ āϰā§āĻā§āϰ āύāĻžāĻŽ āĻŦāĻž Final Dx āϞā§āĻā§āύāύāĻŋāĨ¤ āϤāĻžāĻ āĻ āĻĒāĻžāϰā§āĻļāύ-āĻĒāϰāĻŦāϰā§āϤ⧠āϏāĻāĻā§āϰāĻŽāĻŖ āύāĻŋāĻļā§āĻāĻŋāϤ āĻšāϝāĻŧā§āĻā§âāĻāĻŽāύ āϏāĻŋāĻĻā§āϧāĻžāύā§āϤ āĻļā§āϧ⧠āĻāĻ āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ āĻĨā§āĻā§ āĻĻā§āĻāϝāĻŧāĻž āϝāĻžāĻŦā§ āύāĻžāĨ¤
1. Patient Information & History:-
| Information | Prescription Findings |
| Patient | Md. Ziaur Rahman |
| Age | 35 years |
| Consultation Date | 08-10-2026 |
| Department | ENT |
| Previous Surgery | Endoscopic Tympanoplasty |
| Operated Ear | Right Ear |
| Surgery Date | 29-08-2026 |
| Follow-up Status | Postoperative follow-up |
Assessment confidence: 0.99
C/C â Chief Complaints:-
āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠āϞā§āĻāĻž:
âF/U case of Endo. tymp (Rt) done on 29.08.26â
F/U = Follow-Up (āĻĢāϞā§āĻāĻĒ)
āĻŦāĻžāĻāϞāĻž āĻ āϰā§āĻĨ: āĻĒā§āϰā§āĻŦāĻŦāϰā§āϤ⧠āĻāĻŋāĻāĻŋā§āϏāĻž āĻŦāĻž āĻ āĻĒāĻžāϰā§āĻļāύā§āϰ āĻĒāϰ āϰā§āĻā§āϰ āĻŦāϰā§āϤāĻŽāĻžāύ āĻ āĻŦāϏā§āĻĨāĻž āĻĒāϰā§āĻā§āώāĻž āĻāϰāĻžāϰ āĻāύā§āϝ āĻĒā§āύāϰāĻžāϝāĻŧ āĻāĻŋāĻāĻŋā§āϏāĻā§āϰ āĻāĻžāĻā§ āĻāϏāĻžāĨ¤
āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠āϞā§āĻāĻž:
âF/U case of Endo. tymp (Rt) done on 29.08.26â
āĻāϰ āĻ āϰā§āĻĨ:
- F/U: Follow-Up (āĻĒā§āύāϰāĻžāϝāĻŧ āĻĒāϰā§āĻā§āώāĻž)
- Endo. tymp: Endoscopic Tympanoplasty (āĻāύā§āĻĄā§āϏā§āĻā§āĻĒā§āϰ āϏāĻžāĻšāĻžāϝā§āϝ⧠āĻāĻžāύā§āϰ āĻĒāϰā§āĻĻāĻž āĻŽā§āϰāĻžāĻŽāϤā§āϰ āĻ āĻĒāĻžāϰā§āĻļāύ)
- Rt: Right Ear (āĻĄāĻžāύ āĻāĻžāύ)
- Done on 29.08.26: ⧍⧝ āĻāĻāϏā§āĻ ā§¨ā§Ļ⧍ā§Ŧ āϤāĻžāϰāĻŋāĻā§ āĻ āĻĒāĻžāϰā§āĻļāύ āĻšāϝāĻŧā§āĻā§āĨ¤
â Clinical Meaning: āϰā§āĻā§āϰ āĻĄāĻžāύ āĻāĻžāύā§āϰ āĻĒāϰā§āĻĻāĻžāϰ āĻ āĻĒāĻžāϰā§āĻļāύ āĻšāϝāĻŧā§āĻāĻŋāϞāĨ¤ āĻŦāϰā§āϤāĻŽāĻžāύ⧠āĻ āĻĒāĻžāϰā§āĻļāύā§āϰ āĻĒāϰ āĻāĻžāύā§āϰ āĻ āĻŦāϏā§āĻĨāĻž āĻĒāϰā§āĻā§āώāĻž āĻāϰāĻžāϰ āĻāύā§āϝ āĻāϏā§āĻā§āύāĨ¤
āĻŽāύ⧠āϰāĻžāĻāĻŦā§āύ: F/U āĻā§āύ⧠āϰā§āĻā§āϰ āύāĻžāĻŽ āĻŦāĻž Diagnosis (Dx) āύāϝāĻŧāĨ¤ āĻāĻāĻŋ āϰā§āĻā§āϰ āĻāĻŋāĻāĻŋā§āϏāĻž-āĻĒāϰāĻŦāϰā§āϤ⧠Follow-up visit āĻŦā§āĻāĻžāϝāĻŧāĨ¤
āĻŦāĻžāĻāϞāĻž āĻ āϰā§āĻĨ:
āϰā§āĻā§āϰ āĻĄāĻžāύ āĻāĻžāύ⧠⧍⧝ āĻāĻāϏā§āĻ ā§¨ā§Ļ⧍ā§Ŧ āϤāĻžāϰāĻŋāĻā§ Endoscopic Tympanoplasty āĻāϰāĻž āĻšāϝāĻŧā§āĻāĻŋāϞāĨ¤ āĻŦāϰā§āϤāĻŽāĻžāύ⧠āϰā§āĻā§ āϏā§āĻ āĻ āĻĒāĻžāϰā§āĻļāύā§āϰ Follow-up examination-āĻāϰ āĻāύā§āϝ āĻāϏā§āĻā§āύāĨ¤
Endoscopic Tympanoplasty āĻā§?
āĻāĻžāύā§āϰ āĻĒāϰā§āĻĻāĻžāϰ āĻāĻŋāĻĻā§āϰ āĻŽā§āϰāĻžāĻŽāϤ āĻāĻŦāĻ āĻĒā§āϰāϝāĻŧā§āĻāύ āĻ āύā§āϏāĻžāϰ⧠āĻŽāϧā§āϝāĻāϰā§āĻŖā§āϰ āĻ āύā§āϝāĻžāύā§āϝ āϏāĻŽāϏā§āϝāĻž āϏāĻāĻļā§āϧāύā§āϰ āĻāύā§āϝ āĻāύā§āĻĄā§āϏā§āĻā§āĻĒ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻāϰ⧠āϝ⧠āĻ āĻĒāĻžāϰā§āĻļāύ āĻāϰāĻž āĻšāϝāĻŧ, āϤāĻžāĻā§ Endoscopic Tympanoplasty āĻŦāϞā§āĨ¤
āĻāĻ āĻ āĻĒāĻžāϰā§āĻļāύ āϏāĻžāϧāĻžāϰāĻŖāϤ āĻāϰāĻž āĻšāϝāĻŧ:
- Tympanic membrane perforation
- Chronic otitis media-āϏāĻŽā§āĻĒāϰā§āĻāĻŋāϤ āĻĒāϰā§āĻĻāĻžāϰ āĻāĻŋāĻĻā§āϰ
- āύāĻŋāϰā§āĻŦāĻžāĻāĻŋāϤ āĻā§āώā§āϤā§āϰ⧠Conductive hearing loss-āĻāϰ āĻāĻŋāĻāĻŋā§āϏāĻžāϰ āĻ āĻāĻļ āĻšāĻŋāϏā§āĻŦā§
āϤāĻŦā§ āĻāĻ āϰā§āĻā§āϰ āĻŽā§āϞ āĻ āĻĒāĻžāϰā§āĻļāύā§āϰ āĻāĻžāϰāĻŖāĻāĻŋ āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠āϞā§āĻāĻž āύā§āĻāĨ¤
Doctor āĻāĻŋ Patient History āϞāĻŋāĻā§āĻā§āύ?
āĻšā§āϝāĻžāĻ, āϤāĻŦā§ āϏā§āĻŽāĻŋāϤ āĻĒāϰāĻŋāϏāϰā§āĨ¤
āϞāĻŋāĻā§āĻā§āύ:
- Previous right ear surgery
- Type of surgery
- Date of surgery
- Postoperative follow-up status
āϝā§āϏāĻŦ History āĻāϞā§āϞā§āĻ āύā§āĻ:
Ear discharge, ear pain, hearing loss, tinnitus, vertigo, fever, allergic rhinitis, diabetes, previous antibiotic use āĻāĻŦāĻ drug allergyāĨ¤
āĻ āϰā§āĻĨāĻžā§ āĻŦāϰā§āϤāĻŽāĻžāύ⧠āϰā§āĻā§āϰ āĻāĻžāύ⧠āĻŦā§āϝāĻĨāĻž, āĻĒā§āĻāĻ āĻŦāĻž āĻļā§āϰāĻŦāĻŖāĻļāĻā§āϤāĻŋ āĻšā§āϰāĻžāϏ āϰāϝāĻŧā§āĻā§ āĻāĻŋ āύāĻž, āϤāĻž āĻāĻžāύāĻž āϝāĻžāĻā§āĻā§ āύāĻžāĨ¤
2. O/E â On Examination
āĻāĻŋāĻāĻŋā§āϏāĻā§āϰ āϞā§āĻāĻž:
âRt Ear: Slightly wet deep meatus.â
āĻŦāĻžāĻāϞāĻž āĻ āϰā§āĻĨ:
āĻĄāĻžāύ āĻāĻžāύā§āϰ āĻŦāĻšāĻŋāĻāĻāϰā§āĻŖāύāĻžāϞāĻŋāϰ āĻā§āϤāϰā§āϰ āĻāĻā§āϰ āĻ āĻāĻļ āϏāĻžāĻŽāĻžāύā§āϝ āĻā§āĻāĻž āϰāϝāĻŧā§āĻā§āĨ¤
Clinical Interpretation:-
āĻāĻāĻŋ āĻāĻāĻāĻŋ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ postoperative findingāĨ¤
Deep meatus āĻŦāϞāϤ⧠External Auditory Canal-āĻāϰ āĻāĻā§āϰ āĻ āĻāĻļ āĻŦā§āĻāĻžāύ⧠āĻšāϝāĻŧā§āĻā§āĨ¤
āĻāĻāĻžāύ⧠āϏāĻžāĻŽāĻžāύā§āϝ āĻā§āĻāĻžāĻāĻžāĻŦ āĻĨāĻžāĻāĻžāϰ āϏāĻŽā§āĻāĻžāĻŦā§āϝ āĻāĻžāϰāĻŖ:
- Postoperative healing-related moisture āĻŦāĻž residual dischargeāĨ¤
- Local inflammationāĨ¤
- Otitis externa āĻŦāĻž superficial bacterial infectionāĨ¤
- Middle-ear discharge, āϝāĻĻāĻŋ graft āĻŦāĻž tympanic membrane-āĻāϰ āĻā§āύ⧠āϏāĻŽāϏā§āϝāĻž āĻĨāĻžāĻā§āĨ¤
āĻļā§āϧ⧠slightly wet deep meatus āĻĻā§āĻā§ bacterial infection āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāĻž āϝāĻžāϝāĻŧ āύāĻžāĨ¤
āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠tympanic membrane graft intact āĻāĻā§ āĻāĻŋ āύāĻž, granulation āĻāĻā§ āĻāĻŋ āύāĻž āĻŦāĻž purulent discharge āĻĒāĻžāĻāϝāĻŧāĻž āĻā§āĻā§ āĻāĻŋ āύāĻž, āϤāĻž āĻāϞā§āϞā§āĻ āύā§āĻāĨ¤
Clinical confidence:
- Ear canal slightly wet: 0.99
- Postoperative local inflammation: 0.65
- Confirmed bacterial infection: 0.35 â āĻĒā§āϰāĻŽāĻžāĻŖ āĻ āĻĒāϰā§āϝāĻžāĻĒā§āϤ
3. Investigation â āĻā§ āĻā§ āĻĒāϰā§āĻā§āώāĻž āĻĻāĻŋāϝāĻŧā§āĻā§āύ?
āĻāĻŋāĻāĻŋā§āϏāĻ āĻāĻ āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠āĻā§āύ⧠Investigation āϞā§āĻā§āύāύāĻŋāĨ¤
CBC, ESR, CRP, ear swab, audiometry āĻŦāĻž imaging-āĻāϰ āĻā§āύ⧠āύāĻŋāϰā§āĻĻā§āĻļ āύā§āĻāĨ¤
āϤāĻŦā§ āĻāĻ āϰā§āĻā§āϰ āĻā§āώā§āϤā§āϰ⧠āĻĒā§āϰāϝāĻŧā§āĻāύ āĻ āύā§āϝāĻžāϝāĻŧā§ āύāĻŋāĻŽā§āύā§āĻā§āϤ āĻĒāϰā§āĻā§āώāĻž āĻŦāĻŋāĻŦā§āĻāύāĻž āĻāϰāĻž āϝāĻžāϝāĻŧāĨ¤
| Investigation | Purpose |
| Otoscopy/Otomicroscopy | Ear canal āĻāĻŦāĻ graft āĻĒāϰā§āĻā§āώāĻž |
| Pure Tone Audiometry (PTA) | āĻ āĻĒāĻžāϰā§āĻļāύā§āϰ āĻĒāϰ hearing improvement āĻŽā§āϞā§āϝāĻžāϝāĻŧāύ |
| Ear discharge culture & sensitivity | Persistent/purulent discharge āĻĨāĻžāĻāϞ⧠āĻā§āĻŦāĻžāĻŖā§ āĻļāύāĻžāĻā§āϤ |
| CBC with platelet count | āĻŦāĻŋāĻļā§āώ āĻāϰ⧠Linezolid āĻāϞāĻžāĻāĻžāϞ⧠āϰāĻā§āϤāĻāĻŖāĻŋāĻāĻž āĻĒāϰā§āϝāĻŦā§āĻā§āώāĻŖ |
| Renal function | āĻĒā§āϰāĻžāϏāĻā§āĻāĻŋāĻ āϰā§āĻ āĻŦāĻž āĻāώā§āϧāĻāύāĻŋāϤ āĻā§āĻāĻāĻŋ āĻŽā§āϞā§āϝāĻžāϝāĻŧāύ |
āϏāĻŦāĻā§āϞ⧠āĻĒāϰā§āĻā§āώāĻž āĻāĻāϏāĻā§āĻā§ āĻĒā§āϰāϝāĻŧā§āĻāύ āύā§āĻāĨ¤
4. Advice â āĻāĻŋāĻāĻŋā§āϏāĻ āĻā§ āĻĒāϰāĻžāĻŽāϰā§āĻļ āĻĻāĻŋāϝāĻŧā§āĻā§āύ?
āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύā§āϰ āύāĻŋāĻā§ āϞā§āĻāĻž:
âF/U: ā§§ā§Ļ āĻĻāĻŋāύ āĻĒāϰ āĻāϏāĻŦā§āύāĨ¤â
āĻ āϰā§āĻĨāĻžā§ ā§§ā§Ļ āĻĻāĻŋāύ āĻĒāϰ āĻĒā§āύāϰāĻžāϝāĻŧ ENT specialist-āĻāϰ āĻāĻžāĻā§ Follow-up āĻāϰāϤ⧠āĻŦāϞā§āĻā§āύāĨ¤
āĻ āύā§āϝ āĻā§āύ⧠āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ āϞāĻŋāĻāĻŋāϤ Advice āĻĒāĻžāĻāϝāĻŧāĻž āϝāĻžāϝāĻŧāύāĻŋāĨ¤
5. Complete Drug Analysis â MedEx āĻ āύā§āϝāĻžāϝāĻŧā§Â   (According to Prescription Medicine Analysis)
***1. Tab. Ezolid 600 mg***
Generic Name: Linezolid 600 mg
Bangladesh Brand Name: Ezolid 600 mg
Manufacturer: ACI Limited
MedEx Therapeutic Class
Tab. Ezolid 600 mg (Linezolid) āĻāĻāĻāĻŋ āĻļāĻā§āϤāĻŋāĻļāĻžāϞ⧠Oxazolidinone antibioticāĨ¤
āĻĄāĻžāĻā§āϤāĻžāϰ āĻā§āύ āĻĻāĻŋāϝāĻŧā§āĻā§āύ?
- Postoperative Infection: āĻāĻžāύā§āϰ āĻ āĻĒāĻžāϰā§āĻļāύā§āϰ āĻĒāϰ āĻŦā§āϝāĻžāĻāĻā§āϰāĻŋāϝāĻŧāĻžāϞ āĻāύāĻĢā§āĻāĻļāύ āϏāύā§āĻĻā§āĻš āĻāϰ⧠āĻĨāĻžāĻāϤ⧠āĻĒāĻžāϰā§āύāĨ¤
- MRSA Coverage: MRSA-āĻāϰ āĻŽāϤ⧠resistant Gram-positive bacteria-āĻāϰ āϏāĻāĻā§āϰāĻŽāĻŖā§āϰ āĻāĻļāĻā§āĻāĻž āĻĨāĻžāĻāϞā§āĨ¤
- Ear Examination: āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠âSlightly wet deep meatusâ āϞā§āĻāĻž āĻāĻā§āĨ¤ āĻāĻ āĻā§āĻāĻžāĻāĻžāĻŦ āĻĻā§āĻā§ āĻāĻŋāĻāĻŋā§āϏāĻ āϏāĻāĻā§āϰāĻŽāĻŖā§āϰ āϏāĻŽā§āĻāĻžāĻŦāύāĻž āĻŦāĻŋāĻŦā§āĻāύāĻž āĻāϰ⧠āĻĨāĻžāĻāϤ⧠āĻĒāĻžāϰā§āύāĨ¤
â Clinical Opinion: āϏāĻŽā§āĻāĻŦāϤ postoperative bacterial infection āϏāύā§āĻĻā§āĻš āĻāϰ⧠Linezolid āĻĻāĻŋāϝāĻŧā§āĻā§āύāĨ¤
â ī¸ āĻāĻŋāύā§āϤ⧠āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ: āĻļā§āϧ⧠āĻāĻžāύ āϏāĻžāĻŽāĻžāύā§āϝ āĻā§āĻāĻž āĻĨāĻžāĻāϞā§āĻ MRSA āĻŦāĻž bacterial infection āύāĻŋāĻļā§āĻāĻŋāϤ āĻšāϝāĻŧ āύāĻžāĨ¤ Culture āĻŦāĻž āĻ āύā§āϝ āĻĒā§āϰāĻŽāĻžāĻŖ āĻāĻžāĻĄāĻŧāĻž Linezolid āĻĻā§āĻāϝāĻŧāĻžāϰ āϏā§āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ āĻāĻžāϰāĻŖ āĻāĻžāύāĻž āϏāĻŽā§āĻāĻŦ āύāϝāĻŧāĨ¤
āĻāĻŽāĻžāϰ āĻĒāϰāĻžāĻŽāϰā§āĻļ: 600 mg āĻĻāĻŋāύ⧠⧍ āĻŦāĻžāϰ Ã ā§¨ā§Ļ āĻĻāĻŋāύā§āϰ āĻĒā§āϰāϝāĻŧā§āĻāύā§āϝāĻŧāϤāĻž ENT surgeon-āĻāϰ āϏāĻā§āĻā§ āϝāĻžāĻāĻžāĻ āĻāϰā§āύāĨ¤ āĻāĻ āĻāώā§āϧ āĻāϞāĻžāĻāĻžāϞ⧠weekly CBC monitoring āĻĒā§āϰāϝāĻŧā§āĻāύāĨ¤
Confidence: āϏāĻāĻā§āϰāĻŽāĻŖ āϏāύā§āĻĻā§āĻš āĻāϰ⧠āĻĻā§āĻāϝāĻŧāĻž āĻšāϝāĻŧā§āĻā§âāĻŽāĻžāĻāĻžāϰāĻŋ; MRSA āύāĻŋāĻļā§āĻāĻŋāϤâāĻĒā§āϰāĻŽāĻžāĻŖ āύā§āĻāĨ¤
Macrolides â MedEx-āĻ āĻāĻāĻžāĻŦā§ āϤāĻžāϞāĻŋāĻāĻžāĻā§āĻā§āϤāĨ¤
â ī¸ Classification correction: MedEx-āĻāϰ āĻāĻ āĻļā§āϰā§āĻŖāĻŋāĻŦāĻŋāύā§āϝāĻžāϏāĻāĻŋ āĻŦā§āĻā§āĻāĻžāύāĻŋāĻāĻāĻžāĻŦā§ āϏāĻ āĻŋāĻ āύāϝāĻŧāĨ¤ Linezolid āĻāĻāĻāĻŋ Oxazolidinone antibiotic, Macrolide āύāϝāĻŧāĨ¤ FDA-āĻāϰ official drug information-āĻ āĻāĻāĻŋāĻā§ Oxazolidinone āĻšāĻŋāϏā§āĻŦā§ āĻāĻŋāĻšā§āύāĻŋāϤ āĻāϰā§āĻā§āĨ¤
Pharmacological Class: Oxazolidinone antibacterial
Mechanism of Action: Bacterial 50S ribosomal subunit-āĻāϰ āϏāĻā§āĻā§ āϝā§āĻā§āϤ āĻšāϝāĻŧā§ protein synthesis āĻŦāĻžāϧāĻž āĻĻā§āϝāĻŧāĨ¤
Drug Price
| Details | Price |
| Unit Price | ā§ŗ85.00 |
| Strip Price (10 tablets) | ā§ŗ850.00 |
| 20 days à 2 tablets | ā§ŗ3,400.00 |
Other Available Composition: 400 mg tablet āĻāĻŦāĻ 2 mg/ml IV infusionāĨ¤
MedEx Link: Ezolid 600 mg â MedEx
Use of Purpose â āĻā§āύ āϰā§āĻā§ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻšāϝāĻŧ?
Linezolid āĻŽā§āϞāϤ āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ Gram-positive bacterial infection-āĻāϰ āĻāύā§āϝ āĻŦā§āϝāĻŦāĻšā§āϤ āĻšāϝāĻŧāĨ¤
- MRSA-related infection
- Complicated skin and soft-tissue infection
- Hospital-acquired pneumonia
- Community-acquired pneumonia caused by susceptible organisms
- Vancomycin-resistant Enterococcus (VRE) infection
Linezolid āϏāĻžāϧāĻžāϰāĻŖ Gram-negative āĻā§āĻŦāĻžāĻŖā§āϰ āĻŦāĻŋāϰā§āĻĻā§āϧ⧠āĻāĻžāϰā§āϝāĻāϰ āύāϝāĻŧāĨ¤
Why Doctor Prescribed This Drug in This Patient?
āϏāĻŽā§āĻāĻŦāϤ āĻāĻŋāĻāĻŋā§āϏāĻ āĻ āĻĒāĻžāϰā§āĻļāύ-āĻĒāϰāĻŦāϰā§āϤ⧠bacterial infection āϏāύā§āĻĻā§āĻš āĻāϰā§āĻā§āύ āĻ āĻĨāĻŦāĻž āϏāĻāĻā§āϰāĻŽāĻŖ āύāĻŋāϝāĻŧāύā§āϤā§āϰāĻŖā§āϰ āĻāĻĻā§āĻĻā§āĻļā§āϝ⧠āĻĻāĻŋāϝāĻŧā§āĻā§āύāĨ¤
āĻāĻŋāύā§āϤ⧠āĻļā§āϧ⧠āĻāĻžāύā§āϰ āĻā§āϤāϰ āϏāĻžāĻŽāĻžāύā§āϝ āĻā§āĻāĻžāĻāĻžāĻŦ āĻĨāĻžāĻāĻžāϰ āĻāĻŋāϤā§āϤāĻŋāϤ⧠Linezolid-āĻāϰ āĻĒā§āϰāϝāĻŧā§āĻāύā§āϝāĻŧāϤāĻž āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāĻž āϝāĻžāϝāĻŧ āύāĻžāĨ¤
Prescription Dose: 1+0+1 Ã 20 days
āĻ āϰā§āĻĨāĻžā§ āĻĻāĻŋāύ⧠āĻĻā§āĻāĻŦāĻžāϰ ā§Ŧā§Ļā§Ļ āĻŽāĻŋ.āĻā§āϰāĻž. āĻāϰ⧠⧍ā§Ļ āĻĻāĻŋāύāĨ¤
â ī¸ Important Clinical Concern
Linezolid āĻāĻāĻāĻŋ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ Reserve/Restricted antibioticāĨ¤
⧍ā§Ļ āĻĻāĻŋāύ āĻŦā§āϝāĻŦāĻšāĻžāϰā§āϰ āĻā§āώā§āϤā§āϰ⧠āĻŦāĻŋāĻļā§āώāĻāĻžāĻŦā§ āĻĒā§āϰāϝāĻŧā§āĻāύ:
- Baseline CBC with platelet count
- Weekly CBC monitoring
- Other medications-āĻāϰ āϏāĻā§āĻā§ interaction review
- Infection indication āĻāĻŦāĻ duration āĻĒā§āύāϰā§āĻŽā§āϞā§āϝāĻžāϝāĻŧāύ
Linezolid āĻŦā§āϝāĻŦāĻšāĻžāϰ⧠thrombocytopenia, anemia āĻāĻŦāĻ myelosuppression āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤ Antidepressant āĻāĻžāϤā§āϝāĻŧ āĻāĻŋāĻā§ āĻāώā§āϧā§āϰ āϏāĻā§āĻā§ serotonin syndrome-āĻāϰ āĻā§āĻāĻāĻŋāĻ āϰāϝāĻŧā§āĻā§āĨ¤
My Assessment: Infection āĻŦāĻž resistant organism-āĻāϰ āĻĒā§āϰāĻŽāĻžāĻŖ āĻāĻžāĻĄāĻŧāĻž ⧍ā§Ļ āĻĻāĻŋāύā§āϰ Linezolid prescription-āĻāϰ āϝā§āĻā§āϤāĻŋāĻāϤāĻž āĻāϰāĻ āϝāĻžāĻāĻžāĻ āĻāϰāĻž āĻĒā§āϰāϝāĻŧā§āĻāύāĨ¤
Bangladesh Available Alternative Brands
| Brand | Company | Strength | Unit Price |
| Ezolid | ACI | 600 mg | ā§ŗ85 |
| Arlin | Beximco | 600 mg | ā§ŗ85 |
| Anulid | Healthcare | 600 mg | ā§ŗ85 |
| Linbid | Biopharma | 600 mg | ā§ŗ70 |
āĻāĻā§āϞ⧠āĻāĻāĻ Generic-āĻāϰ āĻŦā§āϰā§āϝāĻžāύā§āĻĄ āĻŦāĻŋāĻāϞā§āĻĒ; āĻāĻŋāύā§āύ āϧāϰāύā§āϰ āĻ ā§āϝāĻžāύā§āĻāĻŋāĻŦāĻžāϝāĻŧā§āĻāĻŋāĻ āύāϝāĻŧāĨ¤
***eta bade onno kon antibiotic dite parto guideline onujai shortcut e bolo***
Guideline āĻ āύā§āϝāĻžāϝāĻŧā§ Ezolid 600 mg (Linezolid)-āĻāϰ āĻĒāϰāĻŋāĻŦāϰā§āϤ⧠āύāĻŋāĻā§āϰ Antibiotic āĻŦāĻŋāĻŦā§āĻāύāĻž āĻāϰāĻž āϝā§āϤ, āϤāĻŦā§ āϏāĻāĻā§āϰāĻŽāĻŖā§āϰ āϧāϰāύ āĻ āύā§āϝāĻžāϝāĻŧā§āĨ¤
| Antibiotic (Generic) | āĻāĻāύ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻāϰāĻž āϝāĻžāϝāĻŧ |
|---|---|
| 1. Ofloxacin 0.3% Ear Drop | Uncomplicated bacterial otitis externa |
| 2. Ciprofloxacin 0.3% Ear Drop | Local bacterial ear infection |
| 3. Ciprofloxacin + Dexamethasone Ear Drop | Ear infection āĻ inflammation āĻāĻāϏāĻā§āĻā§ āĻĨāĻžāĻāϞ⧠|
| 4. Amoxicillin + Clavulanic Acid (Oral) | āĻāĻĒāϝā§āĻā§āϤ bacterial middle-ear infection āĻŦāĻž āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ soft-tissue infection |
| 5. Cephalexin (Oral) | āĻāĻžāύā§āϰ āĻāĻļāĻĒāĻžāĻļā§ MSSA/Streptococcal skin infection āĻŦāĻž cellulitis āĻšāϞ⧠|
â āĻāĻ āϰā§āĻā§āϰ āĻāύā§āϝ āĻā§āύāĻāĻŋ āĻŦā§āĻļāĻŋ āϝā§āĻā§āϤāĻŋāϏāĻāĻāϤ?
āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠âSlightly wet deep meatusâ āϞā§āĻāĻž āĻāĻā§āĨ¤
āϝāĻĻāĻŋ ENT examination-āĻ āĻļā§āϧ⧠uncomplicated bacterial otitis externa āύāĻŋāĻļā§āĻāĻŋāϤ āĻšāϝāĻŧ, āϤāĻžāĻšāϞ⧠Ofloxacin āĻ āĻĨāĻŦāĻž Ciprofloxacin topical preparation āĻĒā§āϰāĻĨāĻŽ āϏāĻžāϰāĻŋāϰ āĻŦāĻŋāĻāϞā§āĻĒ āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤
AAO-HNS Guideline (2014): Uncomplicated otitis externa-āϤ⧠topical antibiotic āĻ āĻā§āϰāĻžāϧāĻŋāĻāĻžāϰ āĻĒāĻžāϝāĻŧ; routine oral antibiotic āĻĒā§āϰāϝāĻŧā§āĻāύ āĻšāϝāĻŧ āύāĻžāĨ¤
â ī¸ Important: āϰā§āĻā§āϰ Tympanoplasty āĻšāϝāĻŧā§āĻā§āĨ¤ āϤāĻžāĻ graft intact āĻāĻŋ āύāĻž āĻĻā§āĻā§ ENT surgeon-āĻā§ ear drop āύāĻŋāϰā§āĻŦāĻžāĻāύ āĻāϰāϤ⧠āĻšāĻŦā§āĨ¤ āĻļā§āϧ⧠āĻā§āĻāĻžāĻāĻžāĻŦā§āϰ āĻāύā§āϝ antibiotic āĻ āĻĒāϰāĻŋāĻšāĻžāϰā§āϝ āύāϝāĻŧāĨ¤
Final Opinion: Linezolid-āĻāϰ āĻĒāϰāĻŋāĻŦāϰā§āϤ⧠āĻ āύā§āϝ oral antibiotic āϏā§āĻŦāϝāĻŧāĻāĻā§āϰāĻŋāϝāĻŧāĻāĻžāĻŦā§ āĻĻā§āĻāϝāĻŧāĻž āĻāĻāĻŋāϤ āύāϝāĻŧāĨ¤ MRSA āĻŦāĻž āĻāĻāĻŋāϞ āϏāĻāĻā§āϰāĻŽāĻŖā§āϰ āĻĒā§āϰāĻŽāĻžāĻŖ āύāĻž āĻĨāĻžāĻāϞ⧠āĻĒā§āϰāĻĨāĻŽā§ oral antibiotic-āĻāϰ āĻĒā§āϰāϝāĻŧā§āĻāύā§āϝāĻŧāϤāĻžāĻ āϝāĻžāĻāĻžāĻ āĻāϰāĻž āĻāĻāĻŋāϤāĨ¤
Reference: AAO-HNS Clinical Practice Guideline, 2014. DOI: 10.1177/0194599813517083āĨ¤
***2. Tab. Fexoral 120 mg***
Generic Name: Fexofenadine Hydrochloride 120 mg
Bangladesh Brand Name: Fexoral 120 mg
Manufacturer: Popular Pharmaceuticals Ltd.
MedEx Therapeutic Class: Anti-histamine
Pharmacological Class: Second-generation selective H1 receptor antagonist
Drug Price
| Details | Price |
| Unit Price | ā§ŗ9.00 |
| Strip Price (10 tablets) | ā§ŗ90.00 |
| Other Strengths | 180 mg tablet, 30 mg/5 ml suspension |
MedEx Link: Fexoral 120 mg â MedEx
Use of Purpose â āĻā§āύ āϰā§āĻā§ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻšāϝāĻŧ?
- Allergic rhinitis
- Seasonal allergy
- Perennial allergic rhinitis
- Chronic urticaria
- Sneezing, rhinorrhea āĻāĻŦāĻ allergic itching
Why Doctor Prescribed in This Patient?
āϏāĻŽā§āĻāĻžāĻŦā§āϝ āĻāĻĻā§āĻĻā§āĻļā§āϝ:
- Nasal allergy āύāĻŋāϝāĻŧāύā§āϤā§āϰāĻŖ
- Nasopharyngeal allergic symptoms āĻāĻŽāĻžāύā§
āϤāĻŦā§ āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠allergic rhinitis āĻŦāĻž nasal congestion-āĻāϰ āĻā§āύ⧠āϞāĻā§āώāĻŖ āϞā§āĻāĻž āύā§āĻāĨ¤
Prescription Dose: 1+0+1 Ã 25 days
āĻ āϰā§āĻĨāĻžā§ ā§§ā§¨ā§Ļ āĻŽāĻŋ.āĻā§āϰāĻž. āĻĻāĻŋāύ⧠āĻĻā§āĻāĻŦāĻžāϰāĨ¤
â ī¸ Dose Review
MedEx āĻ āύā§āϝāĻžāϝāĻŧā§ āĻĒā§āϰāĻžāĻĒā§āϤāĻŦāϝāĻŧāϏā§āĻāĻĻā§āϰ allergic rhinitis-āĻ āĻĒā§āϰāĻāϞāĻŋāϤ āĻĄā§āĻ:
- 60 mg twice daily
- āĻ āĻĨāĻŦāĻž 120 mg once daily
- āĻ āĻĨāĻŦāĻž 180 mg once daily
āĻāĻ āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠120 mg twice daily, āĻ āϰā§āĻĨāĻžā§ 240 mg/day āϞā§āĻāĻž āĻšāϝāĻŧā§āĻā§, āϝāĻž routine labelled allergic rhinitis dosing-āĻāϰ āĻā§āϝāĻŧā§ āĻŦā§āĻļāĻŋāĨ¤
Prescribing doctor-āĻāϰ āϏāĻā§āĻā§ āĻĄā§āĻāĻāĻŋ āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāĻž āĻĒā§āϰāϝāĻŧā§āĻāύāĨ¤
Bangladesh Available Alternative Brands
| Brand | Company | Unit Price |
| Fexoral 120 | Popular | ā§ŗ9 |
| Fexo 120 | Square | ā§ŗ9 |
| Fenadin 120 | Renata | ā§ŗ9 |
| Fenofex 120 | Incepta | ā§ŗ10 |
| Fastel 120 | Radiant | ā§ŗ10 |
āϏāĻŦāĻā§āϞ⧠Fexofenadine 120 mg-āĻāϰ āĻŦā§āϰā§āϝāĻžāύā§āĻĄ āĻŦāĻŋāĻāϞā§āĻĒāĨ¤
***3. Dexonex-C Ear Drop***
Generic Name: Dexamethasone + Chloramphenicol
Composition:
- Dexamethasone 0.1%
- Chloramphenicol 0.5%
Bangladesh Brand Name: Dexonex-C
Manufacturer: Square Pharmaceuticals PLC
MedEx Therapeutic Class
Anti-infectives & antiseptics; Ophthalmic steroid-antibiotic combined preparations
Pharmacological Class:
- Dexamethasone â Corticosteroid
- Chloramphenicol â Amphenicol antibiotic
Drug Price
5 ml bottle: ā§ŗ70.21
MedEx Link: Dexonex-C â MedEx
Use of Purpose
Chloramphenicol āϏāĻāĻŦā§āĻĻāύāĻļā§āϞ āĻŦā§āϝāĻžāĻāĻā§āϰāĻŋāϝāĻŧāĻžāϰ āĻŦāĻŋāϰā§āĻĻā§āϧ⧠āĻāĻžāĻ āĻāϰā§āĨ¤
Dexamethasone āĻĒā§āϰāĻĻāĻžāĻš āĻāĻŽāĻžāϝāĻŧāĨ¤
āĻāĻ combination āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻāϰāĻž āĻšāϝāĻŧ:
- Otitis externa
- Otitis media
- Chronic suppurative otitis media
- āύāĻŋāϰā§āĻŦāĻžāĻāĻŋāϤ āĻā§āώā§āϤā§āϰ⧠ear inflammation-āĻāϰ āĻāĻŋāĻāĻŋā§āϏāĻžāϝāĻŧ
MedEx-āĻ āĻāĻāĻŋ Eye Drop āĻšāĻŋāϏā§āĻŦā§ āϤāĻžāϞāĻŋāĻāĻžāĻā§āĻā§āϤ āĻšāϞā§āĻ ear infection-āĻāϰ indication-āĻ āĻāϞā§āϞā§āĻ āĻāĻā§āĨ¤
Why Doctor Prescribed in This Patient?
O/E-āϤ⧠āϞā§āĻāĻž:
âSlightly wet deep meatus.â
āϏāĻŽā§āĻāĻŦāϤ āĻāĻŋāĻāĻŋā§āϏāĻ āϏā§āĻĨāĻžāύā§āϝāĻŧ āĻĒā§āϰāĻĻāĻžāĻš āĻŦāĻž āϏāύā§āĻĻā§āĻšāĻāύāĻ āϏāĻāĻā§āϰāĻŽāĻŖ āύāĻŋāϝāĻŧāύā§āϤā§āϰāĻŖā§āϰ āĻāĻĻā§āĻĻā§āĻļā§āϝ⧠āĻĻāĻŋāϝāĻŧā§āĻā§āύāĨ¤
Prescription Instruction: āĻĄāĻžāύ āĻāĻžāύ⧠āĻĻāĻŋāĻ¨ā§ ā§Š āĻŦā§āϞāĻž, ā§ āĻĻāĻŋāύāĨ¤
āĻĢā§āĻāĻāĻžāϰ āϏāĻāĻā§āϝāĻžāĻāĻŋ āĻāĻŦāĻŋāϤ⧠âā§Ŧ/ā§Žâ-āĻāϰ āĻŽāϤ⧠āĻĻā§āĻāĻž āϝāĻžāĻā§āĻā§, āĻāĻŋāύā§āϤ⧠āύāĻŋāĻļā§āĻāĻŋāϤāĻāĻžāĻŦā§ āĻĒāĻĄāĻŧāĻž āϝāĻžāĻā§āĻā§ āύāĻžāĨ¤ āϤāĻžāĻ āϏāĻ āĻŋāĻ āϏāĻāĻā§āϝāĻž prescriber āĻŦāĻž pharmacist-āĻāϰ āĻāĻžāĻā§ āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāϤ⧠āĻšāĻŦā§āĨ¤
â ī¸ Important ENT Consideration
Tympanoplasty-āĻĒāϰāĻŦāϰā§āϤ⧠āϰā§āĻā§āϰ āĻā§āώā§āϤā§āϰ⧠graft intact āĻāĻā§ āĻāĻŋ āύāĻž āĻāĻžāύāĻž āĻāϰā§āϰāĻŋāĨ¤
āĻŦāĻŋāĻļā§āώ āĻāϰ⧠āĻŽāϧā§āϝāĻāϰā§āĻŖ āĻāύā§āĻŽā§āĻā§āϤ āĻšāĻāϝāĻŧāĻžāϰ āϏāĻŽā§āĻāĻžāĻŦāύāĻž āĻĨāĻžāĻāϞ⧠non-ototoxic ear preparation āύāĻŋāϰā§āĻŦāĻžāĻāύ āĻāϰāϤ⧠āĻšāϝāĻŧāĨ¤
AAO-HNS guideline-āĻ non-intact tympanic membrane āĻĨāĻžāĻāϞ⧠non-ototoxic topical medicine āĻŦā§āϝāĻŦāĻšāĻžāϰā§āϰ āϏā§āĻĒāĻžāϰāĻŋāĻļ āϰāϝāĻŧā§āĻā§āĨ¤ Chloramphenicol-containing drops-āĻāϰ āĻŽāϧā§āϝāĻāϰā§āĻŖā§ āĻŦā§āϝāĻŦāĻšāĻžāϰā§āϰ āύāĻŋāϰāĻžāĻĒāϤā§āϤāĻž āύāĻŋāϝāĻŧā§āĻ āϏā§āĻŽāĻŋāϤ āĻĒā§āϰāĻŽāĻžāĻŖ āĻ āĻāĻĻā§āĻŦā§āĻ āϰāϝāĻŧā§āĻā§āĨ¤ āϤāĻžāĻ āĻ āĻĒāĻžāϰā§āĻļāύāĻāĻžāϰ⧠ENT surgeon-āĻāϰ āύāĻŋāϰā§āĻĻā§āĻļ āĻāĻžāĻĄāĻŧāĻž āĻĄā§āϰāĻĒ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ āĻŦāĻž āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻŦāĻžāĻĄāĻŧāĻžāύ⧠āĻāĻāĻŋāϤ āύāϝāĻŧāĨ¤
Bangladesh Available Alternative Brands
āĻāĻāĻ Generic combination:
| Brand | Company | 5 ml Price |
| Dexonex-C | Square | ā§ŗ70.21 |
| Dexaguard | Incepta | ā§ŗ70 |
| Dexagen C | General | ā§ŗ70.21 |
| Dextor-C | Eskayef | ā§ŗ70 |
| Sonexa-C | Aristopharma | ā§ŗ70 |
***4. Afrin Nasal Drop 0.05%***
Generic Name: Oxymetazoline Hydrochloride
Strength: 0.05%
Bangladesh Brand Name: Afrin
Manufacturer: Aristopharma Ltd.
MedEx Therapeutic Class
Nasal Anti-histamine preparations, Nasal Decongestants & Other Nasal Preparations
Pharmacological Class: Topical alpha-adrenergic sympathomimetic / Nasal decongestant
Drug Price
10 ml bottle: ā§ŗ70.00
MedEx Link: Afrin 0.05% â MedEx
Use of Purpose
- Nasal congestion
- Allergic rhinitis-āĻāϰ āϏāĻā§āĻā§ āύāĻžāĻ āĻŦāύā§āϧ āĻĨāĻžāĻāĻž
- Common cold-related nasal obstruction
- Sinusitis-associated nasal congestion
- āύāĻŋāϰā§āĻŦāĻžāĻāĻŋāϤ āĻā§āώā§āϤā§āϰ⧠Otitis media-āϤ⧠nasal decongestant āĻšāĻŋāϏā§āĻŦā§
Why Doctor Prescribed in This Patient?
āϏāĻŽā§āĻāĻŦāϤ āύāĻžāĻā§āϰ āĻā§āϤāϰā§āϰ congestion āĻāĻŽāĻžāύā§āϰ āĻāĻĻā§āĻĻā§āĻļā§āϝā§āĨ¤
Oxymetazoline nasal mucosa-āϰ āϰāĻā§āϤāύāĻžāϞāĻŋ āϏāĻāĻā§āĻāĻŋāϤ āĻāϰ⧠āϏāĻžāĻŽāϝāĻŧāĻŋāĻāĻāĻžāĻŦā§ āύāĻžāĻā§āϰ āĻŦāύā§āϧāĻāĻžāĻŦ āĻāĻŽāĻžāϝāĻŧāĨ¤
āϤāĻŦā§ postoperative tympanoplasty-āϤ⧠āĻāĻāĻŋ āύāĻŋāϝāĻŧāĻŽāĻŋāϤ āĻĒā§āϰāϝāĻŧā§āĻāύ āĻšāϝāĻŧâāĻāĻŽāύ āύāϝāĻŧāĨ¤
Prescription Instruction: āĻĻā§āĻ āύāĻžāĻā§ āĻĻāĻŋāĻ¨ā§ ā§Š āĻŦā§āϞāĻž, ā§ āĻĻāĻŋāύāĨ¤ āĻĢā§āĻāĻāĻžāϰ āϏāĻāĻā§āϝāĻž āĻ āϏā§āĻĒāώā§āĻāĨ¤
â ī¸ Important Warning
MedEx āĻ āύā§āϝāĻžāϝāĻŧā§ āϏāĻžāϧāĻžāϰāĻŖ adult dose āĻšāϞ⧠āĻĒā§āϰāϤāĻŋ āύāĻžāĻ⧠⧍âā§Š āĻĢā§āĻāĻāĻž, āĻĻāĻŋāύ⧠āĻĻā§āĻāĻŦāĻžāϰāĨ¤
āĻŦāĻžāϰāĻŦāĻžāϰ āĻŦāĻž āĻĻā§āϰā§āĻāĻĻāĻŋāύ āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻāϰāϞ⧠Rhinitis Medicamentosa / Rebound Nasal Congestion āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤
āϏāĻžāϧāĻžāϰāĻŖāϤ ā§Šâā§Ģ āĻĻāĻŋāύā§āϰ āĻŽāϧā§āϝ⧠āϏā§āĻŽāĻŋāϤ āϰāĻžāĻāĻž āĻāĻžāϞā§āĨ¤ āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύā§āϰ ā§ āĻĻāĻŋāύ āĻ āĻĻāĻŋāĻ¨ā§ ā§Š āĻŦā§āϞāĻž āĻŦā§āϝāĻŦāĻšāĻžāϰā§āϰ āĻĒā§āϰāϝāĻŧā§āĻāύā§āϝāĻŧāϤāĻž āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāĻž āĻāĻāĻŋāϤāĨ¤
āĻāϰā§āĻāĻāĻŋ āĻŦāĻŋāώāϝāĻŧ āĻšāϞ⧠Linezolid-āĻāϰ MAO-inhibiting activity āĻāĻŦāĻ Oxymetazoline-āĻāϰ sympathomimetic action-āĻāϰ āĻāĻžāϰāĻŖā§ āϰāĻā§āϤāĻāĻžāĻĒ āĻŦā§āĻĄāĻŧā§ āϝāĻžāĻāϝāĻŧāĻžāϰ āϏāĻŽā§āĻāĻžāĻŦā§āϝ interaction āĻŦāĻŋāĻŦā§āĻāύāĻž āĻāϰāĻž āĻĒā§āϰāϝāĻŧā§āĻāύāĨ¤
Bangladesh Available Alternative Brands
| Brand | Company | Price |
| Afrin 0.05% | Aristopharma | ā§ŗ70 |
| Azolin 0.05% | ACME | ā§ŗ60 |
| Confree 0.05% | Asiatic | ā§ŗ45 |
| Rynex 0.05% Drop | Incepta | ā§ŗ45 |
| Oxrin 0.05% | Globe | ā§ŗ45 |
6. Doctor’s Diagnosis āĻŦāύāĻžāĻŽ My Clinical Diagnosis
A. Doctor’s Diagnosis
āĻāĻŋāĻāĻŋā§āϏāĻ āĻāϞāĻžāĻĻāĻžāĻāĻžāĻŦā§ Dx: āϞāĻŋāĻā§āύāύāĻŋāĨ¤
āϤāĻŦā§ āĻāϤāĻŋāĻšāĻžāϏ āĻāĻŦāĻ examination āĻ āύā§āϝāĻžāϝāĻŧā§ āύāĻŋāĻļā§āĻāĻŋāϤāĻāĻžāĻŦā§ āĻĒāĻžāĻāϝāĻŧāĻž āϝāĻžāĻā§āĻā§:
Status post right endoscopic tympanoplasty with slightly wet deep external auditory meatus.
āĻŦāĻžāĻāϞāĻž:
āĻĄāĻžāύ āĻāĻžāύā§āϰ āĻĒāϰā§āĻĻāĻžāϰ āĻ āĻĒāĻžāϰā§āĻļāύ-āĻĒāϰāĻŦāϰā§āϤ⧠āĻ āĻŦāϏā§āĻĨāĻž, āϏāĻā§āĻā§ āĻŦāĻšāĻŋāĻāĻāϰā§āĻŖāύāĻžāϞāĻŋāϰ āĻāĻā§āϰ āĻ āĻāĻļā§ āϏāĻžāĻŽāĻžāύā§āϝ āĻā§āĻāĻžāĻāĻžāĻŦāĨ¤
āĻāĻāĻŋ āύāĻĨāĻŋāĻā§āĻā§āϤ clinical finding, āύāĻŋāĻļā§āĻāĻŋāϤ āϏāĻāĻā§āϰāĻŽāĻŖā§āϰ diagnosis āύāϝāĻŧāĨ¤
B. My Working Clinical Diagnosis
Primary Working Diagnosis
Status post right endoscopic tympanoplasty with mild postoperative ear canal moisture; local inflammation or otorrhea to be evaluated.
āĻŦāĻžāĻāϞāĻž:
āĻĄāĻžāύ āĻāĻžāύā§āϰ āĻāύā§āĻĄā§āϏā§āĻā§āĻĒāĻŋāĻ āĻāĻžāĻāĻŽāĻĒā§āϝāĻžāύā§āĻĒā§āϞāĻžāϏā§āĻāĻŋ āĻ āĻĒāĻžāϰā§āĻļāύ-āĻĒāϰāĻŦāϰā§āϤ⧠āĻ āĻŦāϏā§āĻĨāĻž; āĻāĻžāύā§āϰ āĻāĻā§āϰ āĻ āĻāĻļā§ āϏāĻžāĻŽāĻžāύā§āϝ āĻā§āĻāĻžāĻāĻžāĻŦ, āϏā§āĻĨāĻžāύā§āϝāĻŧ āĻĒā§āϰāĻĻāĻžāĻš āĻŦāĻž āĻāĻžāύā§āϰ āϏā§āϰāĻžāĻŦā§āϰ āϏāĻŽā§āĻāĻžāĻŦāύāĻžāĨ¤
Confidence: 0.90 â āύāĻĨāĻŋāĻā§āĻā§āϤ postoperative status āĻāĻŦāĻ ear finding-āĻāϰ āĻāĻŋāϤā§āϤāĻŋāϤā§āĨ¤
āϤāĻŦā§ āϏāĻāĻā§āϰāĻŽāĻŖā§āϰ āĻāĻžāϰāĻŖ, āĻĒā§āϰāĻā§āϤāĻŋ āĻ āĻā§āϏ āϏāĻŽā§āĻĒāϰā§āĻā§ āĻāϤā§āĻŽāĻŦāĻŋāĻļā§āĻŦāĻžāϏ āĻ āύā§āĻ āĻāĻŽāĨ¤
Differential Diagnosis
| Possible Diagnosis | Confidence | Justification |
| Postoperative canal moisture/healing-related change | 0.65 | āϏāĻžāĻŽāĻžāύā§āϝ āĻā§āĻāĻžāĻāĻžāĻŦ āĻĒāĻžāĻāϝāĻŧāĻž āĻā§āĻā§ |
| Local postoperative inflammation | 0.60 | Operated ear āĻ moist finding |
| Otitis externa | 0.45 | āϏāĻŽā§āĻāĻžāĻŦā§āϝ, āĻāĻŋāύā§āϤ⧠canal tenderness/edema āĻāϞā§āϞā§āĻ āύā§āĻ |
| Persistent middle-ear infection | 0.35 | Discharge āĻŦāĻž graft status-āĻāϰ āϤāĻĨā§āϝ āύā§āĻ |
| Graft failure/recurrent perforation | āύāĻŋāϰā§āϧāĻžāϰāĻŖāϝā§āĻā§āϝ āύāϝāĻŧ | Tympanic membrane assessment āĻ āύā§āĻĒāϏā§āĻĨāĻŋāϤ |
āĻāĻ confidence-āĻā§āϞ⧠clinical uncertainty āĻŦā§āĻāĻžāύā§āϰ āĻāύā§āĻŽāĻžāύāĻŋāĻ āĻŽāĻžāύ; āĻā§āύ⧠validated diagnostic score āύāϝāĻŧāĨ¤
Doctor’s Dx āĻāĻŦāĻ My Dx āĻāĻŋ Similar?
āĻšā§āϝāĻžāĻ, āύāĻĨāĻŋāĻā§āĻā§āϤ findings-āĻāϰ āĻā§āώā§āϤā§āϰ⧠āĻŽāĻŋāϞ āϰāϝāĻŧā§āĻā§āĨ¤
āĻāĻŋāĻāĻŋā§āϏāĻ āĻāĻŦāĻ āĻāĻŽāĻžāϰ assessmentâāĻāĻāϝāĻŧ āĻā§āώā§āϤā§āϰā§āĻ āϰā§āĻā§ postoperative tympanoplasty follow-up-āĻ āĻāĻā§āύ āĻāĻŦāĻ operated ear-āĻāϰ āĻāĻā§āϰ āĻ āĻāĻļā§ āĻā§āĻāĻžāĻāĻžāĻŦ āϰāϝāĻŧā§āĻā§āĨ¤
āĻĒāĻžāϰā§āĻĨāĻā§āϝ: āĻāĻŋāĻāĻŋā§āϏāĻ āĻā§āύ⧠āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ bacterial infection Dx āϞā§āĻā§āύāύāĻŋāĨ¤ āĻāĻŽāĻŋāĻ bacterial infection āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāĻāĻŋ āύāĻžāĨ¤ Differential diagnosis āĻšāĻŋāϏā§āĻŦā§ āϏāĻŽā§āĻāĻžāĻŦāύāĻžāĻā§āϞ⧠āĻāϞā§āϞā§āĻ āĻāϰā§āĻāĻŋāĨ¤
āĻ āϰā§āĻĨāĻžā§ āύāĻŋāϰā§āĻĻāĻŋāώā§āĻ infection diagnosis-āĻāϰ āϏāĻā§āĻā§ āϤā§āϞāύāĻž āĻāϰāĻž āϏāĻŽā§āĻāĻŦ āύāϝāĻŧ, āĻāĻžāϰāĻŖ āĻāĻŋāĻāĻŋā§āϏāĻā§āϰ āĻāĻŽāύ diagnosis āϞā§āĻāĻž āύā§āĻāĨ¤
7. Bangladesh-āĻ āĻāĻ āϧāϰāύā§āϰ ENT āϏāĻŽāϏā§āϝāĻžāϝāĻŧ āĻŦā§āϝāĻŦāĻšā§āϤ āĻ āύā§āϝāĻžāύā§āϝ āĻāώā§āϧ
āĻāĻā§āϞ⧠āϏāĻŽā§āĻāĻžāĻŦā§āϝ āĻāĻŋāĻāĻŋā§āϏāĻž-āĻŦāĻŋāĻāϞā§āĻĒā§āϰ āĻāĻĻāĻžāĻšāϰāĻŖ; āĻāĻ āϰā§āĻā§āϰ āĻāύā§āϝ āĻ āϤāĻŋāϰāĻŋāĻā§āϤ āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ āύāϝāĻŧāĨ¤
| Generic | Bangladesh Brand Example | āĻŽā§āϞ āĻŦā§āϝāĻŦāĻšāĻžāϰ |
| Ciprofloxacin 0.3% + Dexamethasone 0.1% | Cipro-D, Neofloxin-D | āĻāĻĒāϝā§āĻā§āϤ āĻā§āώā§āϤā§āϰ⧠inflammatory bacterial ear infection |
| Ofloxacin 0.3% | Vista, Obactin | āϏāĻāĻŦā§āĻĻāύāĻļā§āϞ āĻā§āĻŦāĻžāĻŖā§āĻāύāĻŋāϤ ear infection |
| Ciprofloxacin ophthalmic 0.3% | Beuflox, Bactin | āύāĻŋāϰā§āĻŦāĻžāĻāĻŋāϤ āĻā§āώā§āϤā§āϰ⧠ENT āύāĻŋāϰā§āĻĻā§āĻļāύāĻžāϝāĻŧ topical antibacterial treatment |
| Fexofenadine | Fexo, Fenadin | āϏāĻšāĻžāĻŦāϏā§āĻĨāĻžāύāĻāĻžāϰ⧠allergic rhinitis āĻĨāĻžāĻāϞ⧠|
| Oxymetazoline | Afrin, Rynex | āϏā§āĻŦāϞā§āĻĒāĻŽā§āϝāĻŧāĻžāĻĻāĻŋ nasal congestion relief |
āĻŦāĻžāĻāϞāĻžāĻĻā§āĻļā§ Ciprofloxacin + Dexamethasone combination-āĻāϰ āĻāĻāĻžāϧāĻŋāĻ āĻŦā§āϰā§āϝāĻžāύā§āĻĄ MedEx-āĻ āϤāĻžāϞāĻŋāĻāĻžāĻā§āĻā§āϤ āĻāĻŦāĻ Ear indication āϰāϝāĻŧā§āĻā§āĨ¤
Clinical point: Tympanoplasty-āĻĒāϰāĻŦāϰā§āϤ⧠mild wet ear-āĻāϰ āĻāύā§āϝ āĻā§āύ⧠āĻāĻāĻāĻŋ antibiotic āϏā§āĻŦāϝāĻŧāĻāĻā§āϰāĻŋāϝāĻŧāĻāĻžāĻŦā§ āĻāĻĒāϝā§āĻā§āϤ āύāϝāĻŧāĨ¤ Otomicroscopy, graft status āĻāĻŦāĻ āĻĒā§āϰāϝāĻŧā§āĻāύ āĻšāϞ⧠culture āĻ āύā§āϝāĻžāϝāĻŧā§ āĻāĻŋāĻāĻŋā§āϏāĻž āύāĻŋāϰā§āϧāĻžāϰāĻŖ āĻāϰāϤ⧠āĻšāĻŦā§āĨ¤
8. Clinical Management Review â āĻāĻŋāĻāĻŋā§āϏāĻž āĻāϤāĻāĻž āϝā§āĻā§āϤāĻŋāϏāĻāĻāϤ?
āĻāĻ āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠āϏāĻŦāĻā§āϝāĻŧā§ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ āϤāĻŋāύāĻāĻŋ āĻŦāĻŋāώāϝāĻŧ āĻĒā§āύāϰā§āĻŽā§āϞā§āϝāĻžāϝāĻŧāύ āĻāϰāĻž āĻĒā§āϰāϝāĻŧā§āĻāύāĨ¤
1. Ezolid 600 mg twice daily for 20 days
Linezolid āĻāĻāĻāĻŋ āĻļāĻā§āϤāĻŋāĻļāĻžāϞ⧠antibioticāĨ¤ āĻļā§āϧ⧠mild wet deep meatus āĻĨāĻžāĻāϞ⧠āĻāϤ āĻĻā§āϰā§āĻ systemic antibiotic-āĻāϰ āĻĒā§āϰāϝāĻŧā§āĻāύā§āϝāĻŧāϤāĻž āĻĒā§āϰāϤāĻŋāώā§āĻ āĻŋāϤ āĻšāϝāĻŧ āύāĻžāĨ¤
āϝāĻĻāĻŋ resistant Gram-positive infection āĻŦāĻž āĻāĻāĻŋāϞ postoperative infection-āĻāϰ āĻĒā§āϰāĻŽāĻžāĻŖ āĻĨāĻžāĻā§, āĻĒāϰāĻŋāϏā§āĻĨāĻŋāϤāĻŋ āĻāĻŋāύā§āύ āĻšāϤ⧠āĻĒāĻžāϰā§āĨ¤
2. Fexoral 120 mg twice daily
āĻāĻ āĻĄā§āĻ āĻĒā§āϰāĻāϞāĻŋāϤ allergic rhinitis dosing-āĻāϰ āĻā§āϝāĻŧā§ āĻŦā§āĻļāĻŋāĨ¤ Allergy history āĻāĻŦāĻ āĻĒā§āϰāϝāĻŧā§āĻāύā§āϝāĻŧāϤāĻž āϝāĻžāĻāĻžāĻ āĻāϰāĻž āĻāĻāĻŋāϤāĨ¤
3. Afrin 0.05% three times daily for 7 days
Rebound congestion āĻ Linezolid-āĻāϰ āϏāĻā§āĻā§ āϏāĻŽā§āĻāĻžāĻŦā§āϝ interaction āĻŦāĻŋāĻŦā§āĻāύāĻžāϝāĻŧ dose āĻāĻŦāĻ duration review āĻĒā§āϰāϝāĻŧā§āĻāύāĨ¤
āĻĄāĻžāĻā§āϤāĻžāϰā§āϰ āĻŦā§āϝāĻā§āϤāĻŋāĻāϤ examination-āĻ āĻ āϤāĻŋāϰāĻŋāĻā§āϤ findings āĻĨāĻžāĻāϤ⧠āĻĒāĻžāϰ⧠āϝāĻž āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠āϞā§āĻāĻž āĻšāϝāĻŧāύāĻŋāĨ¤ āϤāĻžāĻ āĻāĻ āĻĒāϰā§āϝāĻŦā§āĻā§āώāĻŖāĻā§āϞ⧠prescribing error āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰ⧠āύāĻžāĨ¤
9. Overview / Summary
| Subject | Final Assessment |
| Chief Complaint | Follow-up after right endoscopic tympanoplasty |
| Past History | Right ear surgery on 29-08-2026 |
| O/E | Right ear slightly wet deep meatus |
| Investigation | None prescribed |
| Advice | Follow-up after 10 days |
| Number of Drugs | 4 |
| Doctor’s Explicit Dx | Not mentioned |
| Working Dx | Post-tympanoplasty status with mild moist deep ear canal |
| Confirmed Bacterial Infection | No |
| Most Important Medication Review | Linezolid 20 days |
| Follow-up Specialist | Operating ENT/Otology surgeon |
10. Actionable Plan â Doctor’s Next Steps
Step 1: ENT Otomicroscopy
Graft healing, perforation, granulation, discharge āĻāĻŦāĻ external canal inflammation āĻŽā§āϞā§āϝāĻžāϝāĻŧāύ āĻāϰāϤ⧠āĻšāĻŦā§āĨ¤
Step 2: Review antibiotic indication
āĻā§āύ Linezolid ⧍ā§Ļ āĻĻāĻŋāύ āĻĻā§āĻāϝāĻŧāĻž āĻšāϝāĻŧā§āĻā§ āϤāĻž āĻ āĻĒāĻžāϰā§āĻļāύāĻāĻžāϰ⧠āĻāĻŋāĻāĻŋā§āϏāĻā§āϰ āĻāĻžāĻ āĻĨā§āĻā§ āύāĻŋāĻļā§āĻāĻŋāϤ āĻāϰāϤ⧠āĻšāĻŦā§āĨ¤ āĻā§āύ⧠culture report āĻŦāĻž āĻĒā§āϰā§āĻŦāĻŦāϰā§āϤ⧠resistant infection-āĻāϰ āĻāϤāĻŋāĻšāĻžāϏ āĻāĻā§ āĻāĻŋ āύāĻž āĻĻā§āĻāϤ⧠āĻšāĻŦā§āĨ¤
Step 3: CBC monitoring
Linezolid āĻāϞāĻŽāĻžāύ āĻĨāĻžāĻāϞ⧠baseline āĻāĻŦāĻ weekly CBC with platelet count āĻĒāϰā§āĻā§āώāĻž āĻĒā§āϰāϝāĻŧā§āĻāύāĨ¤
Step 4: Review medication doses
Fexoral āĻ Afrin-āĻāϰ dose/frequency āĻāĻŦāĻ LinezolidâAfrin interaction āϝāĻžāĻāĻžāĻ āĻāϰāϤ⧠āĻšāĻŦā§āĨ¤ āĻĄāĻžāĻā§āϤāĻžāϰā§āϰ āϏāĻā§āĻā§ āĻāϞā§āĻāύāĻž āĻāĻžāĻĄāĻŧāĻž āύāĻŋāĻā§ āĻĨā§āĻā§ āĻāώā§āϧ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ āĻāϰāĻž āĻāĻāĻŋāϤ āύāϝāĻŧāĨ¤
Step 5: Postoperative precautions
āĻāĻžāύ āĻļā§āĻāύ⧠āϰāĻžāĻāϤ⧠āĻšāĻŦā§āĨ¤ āĻāĻŋāĻāĻŋā§āϏāĻā§āϰ āĻ āύā§āĻŽāϤāĻŋ āĻāĻžāĻĄāĻŧāĻž āĻāĻžāύ⧠āĻĒāĻžāύāĻŋ, cotton bud āĻŦāĻž āĻ āύā§āϝ āĻā§āύ⧠ear drop āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻāϰāĻž āϝāĻžāĻŦā§ āύāĻžāĨ¤ āĻā§āϰ⧠āύāĻžāĻ āĻāĻžāĻĄāĻŧāĻžāĻ āĻāĻĄāĻŧāĻŋāϝāĻŧā§ āĻāϞāϤ⧠āĻšāĻŦā§āĨ¤
Step 6: Follow-up
ā§§ā§Ļ āĻĻāĻŋāύ āĻĒāϰ ENT follow-upāĨ¤ āϤāĻŦā§ āϤā§āĻŦā§āϰ āĻāĻžāύā§āϰ āĻŦā§āϝāĻĨāĻž, āĻā§āĻŦāϰ, āĻĒā§āĻāĻ āĻŦā§āĻĻā§āϧāĻŋ, āύāϤā§āύ hearing loss, vertigo āĻŦāĻž facial weakness āĻšāϞ⧠āĻĻā§āϰā§āϤ ENT assessment āĻĒā§āϰāϝāĻŧā§āĻāύāĨ¤
11. Reference List
A. Standard Medical Textbooks
1. Dhingra PL, Dhingra S. Diseases of Ear, Nose & Throat and Head & Neck Surgery. 8th Edition. Elsevier; 2021.
Relevant Chapters:
- Chapter 8: Diseases of External Ear
- Chapter 10: Disorders of Middle Ear
- Chapter 11: Cholesteatoma and Chronic Otitis Media
- Chapter 79: Ear Surgery and Approaches
- Chapter 83: Myringoplasty
2. Logan Turner’s Diseases of the Nose, Throat and Ear: Head and Neck Surgery. 12th Edition. CRC Press; 2024/2025.
Relevant Section: Otology and Middle Ear Disorders.
B. Clinical Guidelines
3. AAO-HNSF Clinical Practice Guideline: Acute Otitis Externa. 2014.
Recommends non-ototoxic topical preparations when the tympanic membrane is non-intact.
DOI: 10.1177/0194599813517083
āĻāĻ guideline āĻŽā§āϞāϤ Otitis externa-āĻāϰ āĻāύā§āϝ; Tympanoplasty postoperative infection-āĻāϰ āϏāĻŽā§āĻĒā§āϰā§āĻŖ guideline āύāϝāĻŧāĨ¤
4. U.S. FDA / DailyMed â Linezolid Prescribing Information.
Relevant to antibiotic indications, weekly CBC monitoring and interactions.
C. Peer-Reviewed Journals
5. Verschuur HP, de Wever WWH, van Benthem PPG.
Antibiotic prophylaxis in clean and clean-contaminated ear surgery.
Cochrane Database of Systematic Reviews. 2004.
DOI: 10.1002/14651858.CD003996.pub2
āĻāĻ systematic review-āϤ⧠clean āĻŦāĻž clean-contaminated ear surgery-āϤ⧠routine prophylactic antibiotic āĻŦā§āϝāĻŦāĻšāĻžāϰā§āϰ āϏā§āĻĒāώā§āĻ āϏā§āĻŦāĻŋāϧāĻž āĻĒā§āϰāϤāĻŋāώā§āĻ āĻŋāϤ āĻšāϝāĻŧāύāĻŋāĨ¤
6. Haynes DS, Rutka J, Hawke M, Roland PS.
Ototoxicity of ototopical dropsâan update.
Otolaryngologic Clinics of North America. 2007;40(3):669â683.
DOI: 10.1016/j.otc.2007.03.010
Final Clinical Assessment
Prescription-āĻ Dx āϞā§āĻāĻžāϰ āĻāύā§āϝ āϏāĻŦāĻā§āϝāĻŧā§ āϝāĻĨāĻžāϝāĻĨ wording:
Dx: S/P Right Endoscopic Tympanoplasty with mild moist deep external auditory canal.
āĻŦāĻžāĻāϞāĻž: āĻĄāĻžāύ āĻāĻžāύā§āϰ āĻĒāϰā§āĻĻāĻžāϰ āĻ āĻĒāĻžāϰā§āĻļāύ-āĻĒāϰāĻŦāϰā§āϤ⧠āĻ āĻŦāϏā§āĻĨāĻž, āϏāĻā§āĻā§ āĻāĻžāύā§āϰ āĻŦāĻšāĻŋāĻāύāĻžāϞāĻŋāϰ āĻāĻā§āϰ āĻ āĻāĻļā§ āϏāĻžāĻŽāĻžāύā§āϝ āĻā§āĻāĻžāĻāĻžāĻŦāĨ¤
āĻāĻāĻŋ āĻāĻāĻāĻŋ working clinical assessment, confirmed postoperative infection āύāϝāĻŧāĨ¤
āϏāĻŦāĻā§āϝāĻŧā§ āĻā§āϰā§āϤā§āĻŦāĻĒā§āϰā§āĻŖ āϏāĻŋāĻĻā§āϧāĻžāύā§āϤ: āĻāĻžāύā§āϰ graft-āĻāϰ āĻŦāϰā§āϤāĻŽāĻžāύ āĻ āĻŦāϏā§āĻĨāĻž āϝāĻžāĻāĻžāĻ āĻāĻŦāĻ Linezolid 600 mg twice daily for 20 days-āĻāϰ āĻĒā§āϰāϝāĻŧā§āĻāύā§āϝāĻŧāϤāĻž āĻĒā§āύāϰā§āĻŽā§āϞā§āϝāĻžāϝāĻŧāύ āĻāϰāĻžāĨ¤
Ami finally DX ki likhbo?
â Final Diagnosis (Dx):
S/P Right Endoscopic Tympanoplasty with Mild Postoperative Moisture in Deep External Auditory Canal (EAC).
āĻŦāĻžāĻāϞāĻž: āĻĄāĻžāύ āĻāĻžāύā§āϰ āĻĒāϰā§āĻĻāĻžāϰ āĻ āĻĒāĻžāϰā§āĻļāύ-āĻĒāϰāĻŦāϰā§āϤ⧠āĻ āĻŦāϏā§āĻĨāĻž, āϏāĻā§āĻā§ āĻŦāĻšāĻŋāĻāĻāϰā§āĻŖāύāĻžāϞāĻŋāϰ āĻāĻā§āϰ āĻ āĻāĻļā§ āϏāĻžāĻŽāĻžāύā§āϝ āĻā§āĻāĻžāĻāĻžāĻŦāĨ¤
Clinical Confidence: 95% â āĻĒā§āϰā§āϏāĻā§āϰāĻŋāĻĒāĻļāύ⧠āĻāϞā§āϞā§āĻāĻŋāϤ āĻāϤāĻŋāĻšāĻžāϏ āĻ āĻĒāϰā§āĻā§āώāĻžāϰ āĻĢāϞāĻžāĻĢāϞā§āϰ āĻāĻŋāϤā§āϤāĻŋāϤā§āĨ¤
Prescription-āĻ āϏāĻāĻā§āώā§āĻĒā§ āϞāĻŋāĻāĻŦā§āύ:
Dx: S/P Rt. Endoscopic Tympanoplasty with Mild Moist EAC.
â ī¸ Note: Postoperative ear infection āύāĻŋāĻļā§āĻāĻŋāϤ āύāϝāĻŧāĨ¤ āϤāĻžāĻ Otitis Externa āĻŦāĻž CSOM āϞāĻŋāĻāĻŦā§āύ āύāĻž, āϝāϤāĻā§āώāĻŖ āύāĻž ENT examination-āĻ āύāĻŋāĻļā§āĻāĻŋāϤ āĻšāϝāĻŧāĨ¤
Md.Rafiqul Islam Lipu